Purchase Order AG6658P160010
- Not listed
- Roche Diagnostics Corporation received a firm fixed-price purchase order valued at $73,424.72 from a Pacific West Area civilian federal agency for diagnostic equipment and associated service plans. The contract covers a COBAS INTEGRA 400+ analyzer (serial #39-8818) and COBAS E 411 rack (serial #1388-04) with classic service plans, including an administrative modification to address a population error. The award was made without set-aside designation through open competition, with performance...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order for a ROCHE COBAS INTEGRA 400+ service agreement with a ceiling value of $88,932. The contract was originally awarded on November 23, 2015, and this modification represents the exercise of the fourth optional year (Year 5), effective September 1, 2019 through August 31, 2020, which marks the final year of the agreement. The work is to be performed in Castleton, Indiana, and the contract contains no set-aside designation....
- This is a firm fixed-price purchase order awarded by the Plains Area (an alternate name for a federal agency) to Roche Diagnostics Corporation (a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments) for a COBAS INTEGRA 400+ SERVICE AGREEMENT (S/N 410326) with a ceiling value of $13,745.25. The order does not have a set-aside designation, and the ultimate completion date is November 20, 2019. Roche Diagnostics has received numerous federal contract...
- This is a $38,021.42 firm fixed-price delivery order awarded by the Plains Area of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory instruments. The contract is for COBAS E411 and INTEGRA 400 PLUS service agreements, which provides maintenance and support for these specialized clinical chemistry and immunochemistry analyzers used in VA medical facilities. This delivery order is part of...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $5,575.00 by a civilian federal agency (Midwest Area) for a Roche Service Plan covering the LC48 Real-Time PCR System Classic-Silver. The contract was awarded on September 27, 2016, with an ultimate completion date of August 26, 2017. The place of performance is Castleton, Indiana. This award was made without a set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics...
- Roche Diagnostics Corporation was awarded a federal contract on August 14, 2025, by the Defense Health Agency for COBAS Assembly supplies and services. This is a call order under a Blanket Purchase Agreement with a firm fixed-price structure and a ceiling value of $16,080.07. The work will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2025. This contract award carries no set-aside designation, indicating open competition in the federal marketplace. The...
- Roche Diagnostics Corporation was awarded a $5.5K firm fixed price purchase order by a civilian federal agency within the Midwest Area on June 3, 2016, for a LightCycler 480-96 service agreement with quarterly payments. The contract, which did not utilize a set-aside designation, was completed by July 21, 2017, and performed in Castleton, Indiana. As a leading global manufacturer of in vitro diagnostic equipment and reagents, Roche Diagnostics provides the federal government with advanced...
- Roche Diagnostics Corporation was awarded a $190,000 firm fixed-price purchase order by the Pacific West Area, a civilian federal agency, on June 17, 2021, for a Discovery Ultra full system with trade-in of a Discovery XT instrument (model 713276). The contract, which had no set-aside designation, was completed by September 16, 2021, and specifies performance in Castleton, Indiana. The solicitation was posted on May 17, 2021, with a due date of May 31, 2021, allowing Roche to submit its proposal...
- Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, received a delivery order award from the Defense Health Agency on December 1, 2022, for the provision of clinical chemistry and immunoassay analyzers on a cost-per-test basis. This firm fixed-price delivery order, valued at $3.6 million with an ultimate completion date of November 30, 2027, represents a child contract under the General Services Administration's Critical Analyzers, Laboratory...
- The Defense Health Agency awarded a $45.3K delivery order to Roche Diagnostics Corporation for preventative maintenance services on a Roche Instrument COBAS C311 laboratory analyzer, with performance in Castleton, Indiana. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2030. The delivery order is issued under Roche Diagnostics' Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract, which enables federal...
Roche Diagnostics Corporation received a firm fixed-price purchase order from the Plains Area civilian federal agency for service contract premium renewal of a COBAS Integra 400Plus analyzer (Serial Number 39-8491) located in Castleton, Indiana. Awarded on March 22, 2016, with an ultimate completion date of March 6, 2017, the contract ceiling value is $10,308.00. This award utilized no set-aside designation, reflecting open competition in the federal marketplace. The COBAS Integra 400Plus is an automated clinical chemistry analyzer designed to support laboratory operations and diagnostic testing capabilities. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, is a leading supplier of diagnostic technologies to federal healthcare systems. The company holds an extensive portfolio of federal contracts with agencies including the Department of Veterans Affairs and Defense Health Agency, with pricing established through GSA Schedule vehicles such as the Critical Analyzers, Laboratory and In Vitro Diagnostics, Reagents, Test schedules. This contract represents routine maintenance and support services for clinical laboratory equipment, consistent with Roche's broader federal contracting activities in providing diagnostic solutions and equipment support across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 3/22/16 |